Introduction Pertinax Therapeutics is a dynamic specialty pharma firm focusing on revitalizing undervalued drugs with human trial histories. Its flagship PTX-9908 and a suite of SDF-1 mimetics show promising cancer and autoimmune treatment prospects, backed by solid clinical data. |